Mortality, morbidity, and 1-year outcomes of primary elective total hip arthroplasty.
No representative data exist on the risks of adverse outcomes of total hip arthroplasty (THA) in the United Kingdom. A prospective observational study of unselected THA operations was carried out in 5 U.K. regions. Adverse outcomes were assessed from the hospital case notes and general practitioners of 1,100 randomly selected patients and from 7,151 patient-completed questionnaires 3 and 12 months after THA. Three-month mortality was 0.4% to 0.7%. Dislocation and thromboembolic complications were about 3% and 4%. Perioperative fracture, sciatic nerve palsy, aseptic loosening, and revision each had a risk of < or = 1%. At 1 year, 2.6% of patients had undergone another operation on the same hip, 11% reported moderate or severe pain in the operated hip, 23% had severe walking restriction, and 11% were dissatisfied with the operation. Patients and surgeons in the United Kingdom should have access to this information when making a decision about THA.
Williams
Olwen
O
Institute of Public Health, Cambridge, United Kingdom.
Fitzpatrick
Ray
R
Hajat
Shakoor
S
Reeves
Barnaby C
BC
Stimpson
Anne
A
Morris
Richard W
RW
Murray
David W
DW
Rigge
Marianne
M
Gregg
Paul J
PJ
D019644:Arthroplasty, Replacement, Hip / Q000401:mortality*; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D009017:Morbidity; D011183:Postoperative Complications / Q000453:epidemiology; D011446:Prospective Studies; D016896:Treatment Outcome